By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AbbVie 

1 North Waukegan Road

North Chicago  Illinois  60064  U.S.A.
Phone: 1-800-255-5162 Fax: n/a


SEARCH JOBS

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

YEAR FOUNDED:

2013

LEADERSHIP:

CEO: Richard A. Gonzalez

CFO: William J. Chase

JOB:

Please click here for Abbvie job opportunities..

CLINICAL TRIAL:

Please click here for clinical trial information..

FOLLOW ABBVIE:







Key Statistics


Email:
Ownership: Public

Web Site: AbbVie
Employees:
Symbol: ABBV
 



Industry
Pharmaceutical






Company News
Paul Singer’s Hedge Fund Sues AbbVie (ABBV) Over Failed 2014 Shire (SHPG) Merger 8/9/2016 6:24:46 AM
AbbVie (ABBV) Sues Amgen (AMGN) To Fend Off Copy Of $4 Billion Humira Drug 8/5/2016 10:24:54 AM
Drugmakers Like AbbVie (ABBV), Bayer (BAY) Turn Their Eyes to Women’s Health and a Disease With $78 Billion Cost Draws 8/4/2016 7:18:34 AM
AbbVie (ABBV) Reports Second-Quarter 2016 Financial Results 7/29/2016 7:41:08 AM
AbbVie (ABBV) Announces Initiation Of Phase 3 Study Of Venetoclax In Patients With Relapsed Or Refractory Multiple Myeloma 7/29/2016 6:20:08 AM
Enanta Pharmaceuticals, Inc. Announces The U.S.FDA Has Approved AbbVie (ABBV)’s New, Once-Daily VIEKIRA XR (Dasabuvir, Ombitasvir, Paritaprevir And Ritonavir) For The Treatment Of Genotype 1 Chronic Hepatitis C Virus 7/26/2016 10:30:35 AM
X-Chem And AbbVie (ABBV) Enter Into Multi-Target Drug Discovery Partnership 7/26/2016 9:02:44 AM
FDA Green Lights AbbVie (ABBV) Once-Daily Viekira XR for Hepatitis C 7/26/2016 6:12:35 AM
AbbVie (ABBV) Partners Up With Bristol-Myers Squibb (BMY) in Combo Treatment for Lung Cancer 7/25/2016 7:08:42 AM
CHMP Grants Positive Opinion For Shorter Treatment Duration With AbbVie (ABBV)'s VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) For Patients With Genotype 4 Chronic Hepatitis C With Compensated Cirrhosis (Child-Pugh A) 7/25/2016 6:09:56 AM
12345678910...
//-->